Lincoln Pharmaceuticals Ltd.

LINCOLN

₹545.35

0.42% (2.3)

Market Cap

₹1,088 Cr.

P/E

12.60

About

Lincoln Pharmaceuticals Ltd is engaged in the manufacture and marketing of affordable therapeutic products. The product range of the company includes Tablets ,Capsules,Injectables,Syrups and Ointments. Read more

Lincoln Pharmaceuticals Ltd is engaged in the manufacture and marketing of affordable therapeu… Read more

Low

500

52W Range

High

975

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Pledge

Promoters have not pledged a significant portion of their holding
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Other Income

Other income component is making ratios of the company look optically better
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Share price

Share price has increased over last 10 years but more due to rerating
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile

Market Share

0.04 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0.15 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

0.80 %

(as of Nov 21)

Historic

Anti-Malarial - Market Share

0.10 %

(as of Nov 21)

Historic

Blood Related - Market Share

0.02 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

0.11 %

(as of Nov 21)

Historic

Dermatology - Market Share

0.02 %

(as of Nov 21)

Historic

Endocrinology - Market Share

0.12 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

0.19 %

(as of Nov 21)

Historic

Gynecology - Market Share

0.01 %

(as of Feb 21)

Historic

Neurological - Market Share

0.01 %

(as of Jul 21)

Historic

Ophthalmology - Market Share

0.23 %

(as of Nov 21)

Historic

Pain - Market Share

0.11 %

(as of Jul 22)

Historic

Pharmaceutical Sector - Market Share

0.36 %

(as of Nov 21)

Historic

Respiratory - Market Share

0.11 %

(as of Nov 21)

Historic

Stomatological - Market Share

0.01 %

(as of Nov 21)

Historic

Urology - Market Share

0.10 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Lincoln Pharmaceuticals Ltd. Business

What does Lincoln Pharma do?

Lincoln Pharmaceuticals Ltd specializes in producing and promoting cost-effective therapeutic products such as Tablets, Capsules, Injectables, Syrups, and Ointments.

Who are the competitors of Lincoln Pharma?

Lincoln Pharma major competitors are Kwality Pharma, Bharat Parenterals, Anuh Pharma, Wanbury, Shivalik Rasayan, Ind-Swift Lab., Kilitch Drugs(India).
Market Cap of Lincoln Pharma is ₹1,088 Crs.
While the median market cap of its peers are ₹829 Crs.

Is Lincoln Pharma financially stable compared to its competitors?

Lincoln Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	May Aug	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Sep Dec	Jun Sep Dec	Sep	Dec
Investor Presentation	Mar	Mar Jun Sep Dec	Sep Dec	Jun Sep Dec	Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec	Mar Jun	Jun Dec
Conference Call		Mar
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Lincoln Pharmaceuticals Ltd.

View the discussion on ValuePickr

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Lincoln Pharmaceuticals Ltd.